Selected research
Industry Growth & Trends
Global Colorectal Cancer Molecular Diagnostics Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Colorectal Cancer Molecular Diagnostics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Colorectal Cancer Molecular Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Colorectal Cancer Molecular Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Colorectal Cancer Molecular Diagnostics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Colorectal Cancer Molecular Diagnostics market include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent and Daangene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Colorectal Cancer Molecular Diagnostics market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Colorectal Cancer Molecular Diagnostics market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Colorectal Cancer Molecular Diagnostics market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Colorectal Cancer Molecular Diagnostics.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Colorectal Cancer Molecular Diagnostics market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Colorectal Cancer Molecular Diagnostics Market by Company
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Colorectal Cancer Molecular Diagnostics Segment by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Colorectal Cancer Molecular Diagnostics Segment by Application
Hospital
Third-Party Testing Agency
Others
Colorectal Cancer Molecular Diagnostics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Colorectal Cancer Molecular Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Colorectal Cancer Molecular Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Colorectal Cancer Molecular Diagnostics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Colorectal Cancer Molecular Diagnostics companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Polymerase Chain Reaction PCR
- Molecular Hybridization
- Biochip
- Others
Applications
- Hospital
- Third-Party Testing Agency
- Others
Companies covered
- Roche Diagnostics
- Abbott
- Thermo Fisher
- Qiagen
- Illumina
- Biomerieux
- Bio-Rad
- Agilent
- Daangene
- Amoydx
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Colorectal Cancer Molecular Diagnostics Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Colorectal Cancer Molecular Diagnostics Market Size by Region (2021-2032)
- 1.4.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region (2021-2026)
- 1.4.2 Global Colorectal Cancer Molecular Diagnostics Market Size by Region (2027-2032)
- 1.5 Key Regions Colorectal Cancer Molecular Diagnostics Market Size (2021-2032)
- 1.5.1 North America Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.4 South America Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (2021-2032)
2 Colorectal Cancer Molecular Diagnostics Market by Type
- 2.1 Type Introduction
- 2.1.1 Polymerase Chain Reaction PCR
- 2.1.2 Molecular Hybridization
- 2.1.3 Biochip
- 2.1.4 Others
- 2.2 Global Colorectal Cancer Molecular Diagnostics Market Size by Type
- 2.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Overview by Type (2021-2032)
- 2.2.2 Global Colorectal Cancer Molecular Diagnostics Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Colorectal Cancer Molecular Diagnostics Market Size Forecasted by Type (2027-2032)
- 2.3 Global Colorectal Cancer Molecular Diagnostics Market Size by Regions
- 2.3.1 North America Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Type (2021-2026)
3 Colorectal Cancer Molecular Diagnostics Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Third-Party Testing Agency
- 3.1.3 Others
- 3.2 Global Colorectal Cancer Molecular Diagnostics Market Size by Application
- 3.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Overview by Application (2021-2032)
- 3.2.2 Global Colorectal Cancer Molecular Diagnostics Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Colorectal Cancer Molecular Diagnostics Market Size Forecasted by Application (2027-2032)
- 3.3 Global Colorectal Cancer Molecular Diagnostics Market Size by Regions
- 3.3.1 North America Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Colorectal Cancer Molecular Diagnostics Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Colorectal Cancer Molecular Diagnostics Industry Trends
- 4.2 Colorectal Cancer Molecular Diagnostics Industry Drivers
- 4.3 Colorectal Cancer Molecular Diagnostics Industry Opportunities and Challenges
- 4.4 Colorectal Cancer Molecular Diagnostics Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Colorectal Cancer Molecular Diagnostics Revenue (2021-2026)
- 5.2 Global Colorectal Cancer Molecular Diagnostics Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Colorectal Cancer Molecular Diagnostics Key Company Headquarters & Area Served
- 5.4 Global Colorectal Cancer Molecular Diagnostics Company, Product Type & Application
- 5.5 Global Colorectal Cancer Molecular Diagnostics Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Colorectal Cancer Molecular Diagnostics Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Colorectal Cancer Molecular Diagnostics Players Market Share by Revenue in 2025
- 5.6.3 2025 Colorectal Cancer Molecular Diagnostics Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Roche Diagnostics
- 6.1.1 Roche Diagnostics Company Information
- 6.1.2 Roche Diagnostics Business Overview
- 6.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.1.5 Roche Diagnostics Recent Developments
- 6.2 Abbott
- 6.2.1 Abbott Company Information
- 6.2.2 Abbott Business Overview
- 6.2.3 Abbott Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Abbott Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.2.5 Abbott Recent Developments
- 6.3 Thermo Fisher
- 6.3.1 Thermo Fisher Company Information
- 6.3.2 Thermo Fisher Business Overview
- 6.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.3.5 Thermo Fisher Recent Developments
- 6.4 Qiagen
- 6.4.1 Qiagen Company Information
- 6.4.2 Qiagen Business Overview
- 6.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Qiagen Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.4.5 Qiagen Recent Developments
- 6.5 Illumina
- 6.5.1 Illumina Company Information
- 6.5.2 Illumina Business Overview
- 6.5.3 Illumina Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Illumina Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.5.5 Illumina Recent Developments
- 6.6 Biomerieux
- 6.6.1 Biomerieux Company Information
- 6.6.2 Biomerieux Business Overview
- 6.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Biomerieux Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.6.5 Biomerieux Recent Developments
- 6.7 Bio-Rad
- 6.7.1 Bio-Rad Company Information
- 6.7.2 Bio-Rad Business Overview
- 6.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Bio-Rad Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.7.5 Bio-Rad Recent Developments
- 6.8 Agilent
- 6.8.1 Agilent Company Information
- 6.8.2 Agilent Business Overview
- 6.8.3 Agilent Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Agilent Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.8.5 Agilent Recent Developments
- 6.9 Daangene
- 6.9.1 Daangene Company Information
- 6.9.2 Daangene Business Overview
- 6.9.3 Daangene Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Daangene Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.9.5 Daangene Recent Developments
- 6.10 Amoydx
- 6.10.1 Amoydx Company Information
- 6.10.2 Amoydx Business Overview
- 6.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Amoydx Colorectal Cancer Molecular Diagnostics Product Portfolio
- 6.10.5 Amoydx Recent Developments
7 North America
- 7.1 North America Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 7.3 North America Colorectal Cancer Molecular Diagnostics Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 8.3 Europe Colorectal Cancer Molecular Diagnostics Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 10.3 South America Colorectal Cancer Molecular Diagnostics Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst